Author

Vineet Kumar

Observed names: Kumar, Vineet, Vineet Kumar Rai

Observed institutions: University of Delhi, New Jersey Institute of Technology, Merck & Co., Inc., Rahway, NJ, USA (United States), Biogen (United States), National University of Singapore, Pfizer (United States), Genentech, University of Washington, Aarhus University Hospital, Maharani Laxmi Bai Medical College, The Barbara Ann Karmanos Cancer Institute, Bristol-Myers Squibb (United States), Indo Soviet Friendship College of Pharmacy, Government of Himachal Pradesh, Frederick National Laboratory for Cancer Research, Stanford Medicine, Gilead Sciences (United States), National Cancer Institute, AstraZeneca (United States), Sathyabama Institute of Science and Technology, Leidos Biomedical Research Inc. (United States), BioIVT (United States), Mahamana Pandit Madan Mohan Malaviya Cancer Centre, Life Sciences Institute, Newcastle University, Science Applications International Corporation (United States), Stanford University, Seagen (United States)

ORCID: 0000-0001-7193-9646

Observed ORCID: 0000-0001-7193-9646

OpenAlex ID: A5100717677

Naturally occurring aristolactams, aristolochic acids and dioxoaporphines and their biological activities

2003 · Vineet Kumar, Poonam, et al. · Natural Product Reports · 192

Study on the potential anti-cancer activity of phosphonium and ammonium-based ionic liquids

2009 · Vineet Kumar, Sanjay V. Malhotra · Bioorganic & Medicinal Chemistry Letters · 156

A profile of the in vitro anti-tumor activity of imidazolium-based ionic liquids

2009 · Sanjay V. Malhotra, Vineet Kumar · Bioorganic & Medicinal Chemistry Letters · 142

Targeting the Hsp40/Hsp70 Chaperone Axis as a Novel Strategy to Treat Castration-Resistant Prostate Cancer

2018 · Michael A. Moses, Yeong Sang Kim, et al. · Cancer Research · 120

Synthesis of nucleoside-based antiviral drugs in ionic liquids

2008 · Vineet Kumar, Sanjay V. Malhotra · Bioorganic & Medicinal Chemistry Letters · 68

Novel carbohydrate-based chiral ammonium ionic liquids derived from isomannide

2008 · Vineet Kumar, Cao Pei, et al. · Tetrahedron Asymmetry · 64

Novel thiocoumarins as inhibitors of TNF-α induced ICAM-1 expression on human umbilical vein endothelial cells (HUVECs) and microsomal lipid peroxidation

2005 · Sarvesh Kumar, Brajendra K. Singh, et al. · Bioorganic & Medicinal Chemistry · 64

Microwave mediated synthesis of spiro-(indoline-isoxazolidines): mechanistic study and biological activity evaluation

2005 · Raunak, Vineet Kumar, et al. · Tetrahedron · 63

Y box binding protein 1 inhibition as a targeted therapy for ovarian cancer

2021 · Dhanir Tailor, Angel Resendez, et al. · Cell chemical biology · 55

Identification of a Small Molecule That Selectively Inhibits ERG-Positive Cancer Cell Growth

2018 · Ahmed A. Mohamed, Charles P. Xavier, et al. · Cancer Research · 55

Imidazolium-derived ionic salts induce inhibition of cancerous cell growth through apoptosis

2014 · Sanjay V. Malhotra, Vineet Kumar, et al. · MedChemComm · 50

Ionic Liquids as Pharmaceutical Salts: A Historical Perspective

2010 · Vineet Kumar, Sanjay V. Malhotra · ACS symposium series · 46

‘Green’ methodology for efficient and selective benzoylation of nucleosides using benzoyl cyanide in an ionic liquid

2005 · Ashok K. Prasad, Vineet Kumar, et al. · Bioorganic & Medicinal Chemistry · 46

Identification of the First Inhibitor of the GBP1:PIM1 Interaction. Implications for the Development of a New Class of Anticancer Agents against Paclitaxel Resistant Cancer Cells

2014 · Mirko Andreoli, Marco Persico, et al. · Journal of Medicinal Chemistry · 44

PDF

Investigations toward new lead compounds from medicinally important plants

2005 · Ashok K. Prasad, Vineet Kumar, et al. · Pure and Applied Chemistry · 42

PDF

FeCl3-Catalyzed Pechmann Synthesis of Coumarins in Ionic Liquids

2008 · Vineet Kumar, Shilpi Tomar, et al. · Synthetic Communications · 41

Enhanced solubility and selective benzoylation of nucleosides in novel ionic liquid

2006 · Vineet Kumar, Virinder S. Parmar, et al. · Tetrahedron Letters · 40

Novel 3,5-bis(arylidiene)-4-piperidone based monocarbonyl analogs of curcumin: anticancer activity evaluation and mode of action study

2014 · Anuj Thakur, Sunny Manohar, et al. · MedChemComm · 37

Asymmetric Catalysis in Ionic Liquids

2007 · Sanjay Malhotra, Vineet Kumar, et al. · Current Organic Synthesis · 36

SU086, an inhibitor of HSP90, impairs glycolysis and represents a treatment strategy for advanced prostate cancer

2022 · Meghan A. Rice, Vineet Kumar, et al. · Cell Reports Medicine · 35

PDF

Epithelial‐to‐Mesenchymal Transition (EMT) and Drug Response in Dynamic Bioengineered Lung Cancer Microenvironment

2018 · Vigneshwaran Mani, Zhonglin Lyu, et al. · Advanced Biosystems · 32

Dual role of ionic liquids as phase transfer catalyst and solvent for glycosidation reactions

2011 · Vineet Kumar, Ian Jamie Talisman, et al. · RSC Advances · 29

Methoxychalcone inhibitors of androgen receptor translocation and function

2012 · Yeong Sang Kim, Vineet Kumar, et al. · Bioorganic & Medicinal Chemistry Letters · 26

Selective modulation of the cannabinoid type 1 (CB 1 ) receptor as an emerging platform for the treatment of neuropathic pain

2019 · Samuel D. Banister, Kaavya Krishna Kumar, et al. · MedChemComm · 23

PDF

Structural modifications of nucleosides in ionic liquids

2010 · Vineet Kumar, Virinder S. Parmar, et al. · Biochimie · 23

Works count: 93

Citation count: 1,523

H-index: 22

I10-index: 32